Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*
Sabine Käyser(German Cancer Research Center), Mark J. Levis(Sidney Kimmel Cancer Center), Gregor Warsow(German Cancer Research Center), Michael Krämer(University Hospital Carl Gustav Carus), Andrew M. Brunner(Harvard University), Petr Cetkovský(Charles University), Roland B. Walter(Rafael Advanced Defense Systems (Israel)), Alan K. Burnett(Cardiff University), Gerhard Ehninger(University Hospital Carl Gustav Carus), Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Christoph Röllig(University Hospital Carl Gustav Carus), Ralitsa Langova(German Cancer Research Center), Carsten Müller‐Tidow(Heidelberg University), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Zdeněk Ráčil(Masaryk University), Robert K. Hills(Cancer Research UK Clinical Trials Unit), Maria R. Baer(University of Maryland, Baltimore), Richard F. Schlenk(German Cancer Research Center), Jiřı́ Mayer(Masaryk University), Zuzana Šustková(Masaryk University), Benedikt Brors(German Cancer Research Center), Elihu H. Estey(University of Washington), Tomáš Szotkowski(University Hospital Olomouc), Anthony D. Ho(Heidelberg University), Uwe Platzbecker(National Center for Tumor Diseases), Angela Schulz(German Cancer Research Center), Pavel Žák(University Hospital Hradec Králové), David Grimwade(King's College School), Francesca Guijarro(Hospital Clínic de Barcelona), Carole Shaw(University of Washington), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 33
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k